Efficacy of Melatonin on Postoperative Outcomes After Hysterectomy: A Randomized, Double-Blind, Placebo-Controlled Trial
preprint
OA: green
CC0
Abstract
Abstract Background: Melatonin became a part of multimodal analgesia in several recent studies because of its analgesic, anxiolytic and anti-inflammatory properties. Incidence of anxiety and pain in patients undergoing hysterectomy is not low. Moreover, preoperative anxiety is related to postoperative pain. The hypothesis of this study was whether melatonin could improve pain and other postoperative conditions after hysterectomy. Methods: A randomized, double-blinded, placebo-controlled trial involved recruitment of 54 patients, aged between 18 and 65 years old, planned to undergo hysterectomy, with or without oophorectomy under spinal anesthesia. The patients were allocated to receive 4 mg prolonged-release melatonin at night before surgery and in the morning before surgery or 2 doses of placebo at the same time point. Morphine consumption within 24 hours with patient-controlled analgesia machine and visual analog scale (VAS) pain score were recorded. In addition, quality of sleep, Thai standard anxiety level score, fatigue, general well-being and satisfaction score were measured by a blinded assessor and analyzed. Results: Mean of cumulative dose of morphine consumption in melatonin and placebo group were 33.04 ±10.42 and 42.63 ±8.21 mg, respectively. (p < 0.001) Mean of postoperative VAS pain scale was lower in the melatonin group at recovery room arrival (T0) (23.41 vs 8.07, p = 0.01). However, there was not a significant difference between postoperative groups at 1(T1), 6 (T6) and 24 h (T24). Fatigue and general well-being score in the melatonin group were better than the placebo group. Conclusion: Prolonged-release formulation of melatonin decreased pain intensity in post anesthetic care room and lowered doses of postoperative morphine within 24 hours after surgery. Postoperative fatigue, general well-being and satisfaction scores were better in the treatment group. However, there was no anxiety and sleep quality improvement. Melatonin may be an additional choice of multimodal analgesia for hysterectomy. Clinical trial registration : TCTR20140516001, Registered 16 May, 2014, http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=1076, Efficacy of melatonin on postoperative outcomes after hysterectomy: a randomised, doubl-blinded, placebo-controlled trial
My notes (saved in your browser only)
Outcome instruments
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (26)
- Incidence and risk factors of chronic pain following hysterectomy among Southern Jiangsu Chinese Women via openalex
- W1506478604 via openalex
- W1972833721 via openalex
- W1973010465 via openalex
- W1976030611 via openalex
- W1979935408 via openalex
- W2001870407 via openalex
- W2002015440 via openalex
- W2006932297 via openalex
- W2035190414 via openalex
- W2059300138 via openalex
- W2062640963 via openalex
- W2071291748 via openalex
- W2110757770 via openalex
- W2133347503 via openalex
- W2224205824 via openalex
- W2397590910 via openalex
- W2505893812 via openalex
- W2547806892 via openalex
- W2914681454 via openalex
- W2976988264 via openalex
- W3024821641 via openalex
- W3027686317 via openalex
- W4253669856 via openalex
- W179031766 via openalex
- W6639922678 via openalex
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK